04/03/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

04/03/2025

Mar 4, 2025, 08:07 | Blog
Would you delay life-saving cancer treatment to become a mother? - CancerWorld
CancerWorld shared a post on X: "Would you delay life-saving cancer treatment to become a…
Mar 4, 2025, 08:05 | Blog
Carmen Monge-Montero: Blue March - time to raise awareness about colorectal cancer
Carmen Monge-Montero, Researcher and patient advocate at Youth Cancer Europe, posted on LinkedIn: "Hi Network!…
Mar 4, 2025, 08:01 | Blog
Dana-Farber has elected the largest cohort of physician-investigators to the 2025 class of ASCI
Dana-Farber Cancer Institute shared a post on LinkedIn "Dana-Farber has elected the largest cohort of…
Mar 4, 2025, 07:57 | Blog
Nicole D. Fleming: Fred Hutchinson Cancer Center Director’s Retreat
Fred Hutchinson Cancer Center recently convened its Director's Retreat, fostering discussions on strategic priorities and…
Mar 4, 2025, 07:55 | Blog
Moy Bracken will be attending the World Evidence, Pricing, and Access Congress
Moy Bracken, Research Unit Manager at Access to Medicine Foundation, shared a post on LinkedIn:…
Mar 4, 2025, 07:47 | Blog
Gilles Vassal at the International Convention Defeating Childhood Cancer
SIOP Europe shared a post on LinkedIn by WHO Regional Office for Europe, adding: "Our…
Mar 4, 2025, 07:41 | Blog
Pramesh CS: CReDO workshop 2025 is on
Pramesh CS, Director of the Tata Memorial Hospital, shared a post on X: "And, CReDO…
Mar 4, 2025, 07:39 | Blog
Michael Sapienza: Ending colorectal cancer as we know it at DC ScopeItOut
Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, shared a post on Facebook:…
Mar 4, 2025, 07:35 | Insight
Drew Moghanaki: Outcomes for stage I NSCLC treated with minimally invasive surgery or SABR
Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology at…
Mar 4, 2025, 07:35 | Blog
DESTINY-Breast07 phase Ib/II trial presented at ESMO TAT 2025
ESMO posted on LinkedIn: "Updated results presented at ESMO TAT 2025 from the DESTINY-Breast07 phase…
All: 105 Posts: 61 - 70
Special Coverage